Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 7/20 | 0.46 |
| ▸ | ELANE | P08246 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SORD | Q00796 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2667239 | 1.00 | SGMS2 (0.46) | SGMS2ELANEALDH1A1KDM4ENPC1 | |
| SCHEMBL13053003 | 0.77 | SGMS2 (0.51) | SGMS2ELANEALDH1A1KDM4ENPC1 | |
| SCHEMBL13052972 | 0.77 | SGMS2 (0.51) | SGMS2ELANEALDH1A1KDM4ENPC1 | |
| SCHEMBL1074019 | 0.75 | ALDH1A1 (0.41) | SGMS2ALDH1A1KDM4ENPC1TP53 | |
| SCHEMBL5140187 | 0.75 | ALDH1A1 (0.41) | SGMS2ALDH1A1KDM4ENPC1TP53 | |
| SCHEMBL29657370 | 0.75 | ALDH1A1 (0.41) | SGMS2ALDH1A1KDM4ENPC1TP53 | |
| SCHEMBL845891 | 0.75 | ALDH1A1 (0.41) | SGMS2ALDH1A1KDM4ENPC1TP53 | |
| SCHEMBL10278989 | 0.75 | ALDH1A1 (0.41) | SGMS2ALDH1A1KDM4ENPC1TP53 | |
| SCHEMBL30988533 | 0.75 | ELANE (0.44) | SGMS2ELANEALDH1A1KDM4ENPC1 | |
| SCHEMBL30648204 | 0.75 | ALDH1A1 (0.41) | SGMS2ALDH1A1KDM4ENPC1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4514788-A1 | NITROGEN COMPRISING HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH GPR55 RECEPTOR | Cerevance, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| WO-2023209368-A1 | NITROGEN COMPRISING HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH GPR55 RECEPTOR | Cerevance, Inc. (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023064218-A1 | TYRO3 INHIBITORS | Halia Therapeutics, Inc. (US) | 2023-04-20 | — | — | WO | disclosed |